CLINICAL_TRIALS
trial_result
· 2012-03-29
Clinical Trial Update: Glycine Treatment of Prodromal Symptoms [Phase 2]
Summary
Phase 2 trial evaluating glycine for prodromal symptoms in schizophrenia has completed; the update outlines the study's efficacy and safety findings.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED